AshiBio
Burlingame, US · 2 known investors
Find your way into AshiBio
559 people in our graph share verified history with the AshiBio team — schools, employers, funds. One of them is your warm intro.
Adam Valkinunlockedknows Deborah Wenkert · together at Harvard University (overlapped)
knows the team · via Tufts University School of Medicine
×8knows the team · via Harvard University
knows the team · via Washington University School of Medicine in St. Louis
knows the team · via Amgen
āshibio is a biotech company developing novel therapies for rare bone and connective tissue disorders, led by a team of scientists, physicians and drug developers. Its lead product is the antibody andecaliximab.
Founders & leadership
PB
Pankaj BhargavainFounder & Chief Executive Officer
VS
Victoria SmithChief Scientific Officer
DW
Deborah WenkertinChief Medical OfficerDeborah Wenkert is Chief Medical Officer of AshiBio, a biotech company developing therapies for rare bone and connective tissue disorders. She is a pediatric rheumatologist with experience in rheumatology, bone disease, and rare disorders across academic and industry settings.
JS
Joseph SarretActing Chief Operating Officer
BS
Investors · 2
Competitors · 7
by search overlap
AskBio5 shared keywordsAskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.
Azbio4 shared keywordsAZBio is a statewide industry association and advocate for Arizona's bioscience sector, connecting biotech, medtech, and healthcare organizations to support the state's life science ecosystem. The organization provides resources, leadership, and advocacy to establish Arizona as a top-ten life science state.
Axbio4 shared keywordsA life sciences company offering nanopore sequencing instruments and automated library preparation systems for molecular biology research.
Akamis Bio4 shared keywordsAkamis Bio develops oncolytic immunotherapies for colorectal cancer treatment, aiming to offer alternatives to surgery that preserve patient function and quality of life. The company serves patients and clinicians in the oncology market.
AviadoBio Website3 shared keywordsAviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.
HiFiBiO Therapeutics3 shared keywordsHiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics. The platform supports target discovery, antibody selection, and predictive biomarker identification for drug development.
Avivo Biomedical Inc.3 shared keywordsAvivo develops enzyme-based technology to convert blood types and enable organ compatibility, increasing access to transfusions and transplants while reducing waste in healthcare systems. The company serves hospitals, transplant centers, military and emergency care settings with a platform designed to integrate into existing clinical workflows.
Companies competing with AshiBio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does AshiBio do?
- āshibio is a biotech company developing novel therapies for rare bone and connective tissue disorders, led by a team of scientists, physicians and drug developers. Its lead product is the antibody andecaliximab.
- Who founded AshiBio?
- AshiBio was founded by Pankaj Bhargava.
- Who are AshiBio's investors?
- AshiBio's investors include Agent Capital, MPM BioImpact.
- Where is AshiBio headquartered?
- AshiBio is headquartered in Burlingame, US.